Wellington Management Group LLP Next Cure, Inc. Transaction History

Wellington Management Group LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.74 - $8.02 $162,744 - $193,650	-24,146 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$7.6 - $10.28 $11,149 - $15,080	-1,467 Reduced 5.73%	24,146 $193,000
Q1 2021 May 17, 2021	SELL	$9.81 - $13.88 $171,155 - $242,164	-17,447 Reduced 40.52%	25,613 $256,000
Q4 2020 Feb 12, 2021	SELL	$9.47 - $12.43 $3.21 Million - $4.21 Million	-338,928 Reduced 88.73%	43,060 $469,000
Q3 2020 Nov 16, 2020	SELL	$8.15 - $21.17 $781,878 - $2.03 Million	-95,936 Reduced 20.07%	381,988 $3.36 Million
Q2 2020 Aug 14, 2020	SELL	$21.19 - $40.2 $1.02 Million - $1.93 Million	-47,963 Reduced 9.12%	477,924 $10.2 Million
Q1 2020 May 14, 2020	SELL	$32.32 - $58.37 $2.15 Million - $3.88 Million	-66,528 Reduced 11.23%	525,887 $19.5 Million
Q4 2019 Feb 11, 2020	BUY	$25.0 - $92.22 $14.8 Million - $54.6 Million	592,415 New	592,415 $33.4 Million

16.2M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $21.9M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.